Company profile for IMV

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

IMV is a clinical-stage immuno-oncology company that wants to transform the way we engage human immunity to address some of the most complex, devastating diseases in today’s medical landscape. Our technology provides the foundation of our Company and underscores the novel benefits of our product candidates across multiple therapeutic markets. Our human immune system is bombarded with countless messages and directives at any ...
IMV is a clinical-stage immuno-oncology company that wants to transform the way we engage human immunity to address some of the most complex, devastating diseases in today’s medical landscape. Our technology provides the foundation of our Company and underscores the novel benefits of our product candidates across multiple therapeutic markets. Our human immune system is bombarded with countless messages and directives at any given moment. The key, we believe, is making sure that the right directives get through, safely and efficiently, to help our body do what it is already designed to do: fight serious diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
2875 Boulevard Laurier Delta 1, Suite 220 Québec, Québe
Telephone
Telephone
+1 (902) 492-1819
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20230726971716/en

BUSINESSWIRE
26 Jul 2023

https://www.businesswire.com/news/home/20230331005336/en

BUSINESSWIRE
31 Mar 2023

https://www.businesswire.com/news/home/20230327005650/en

BUSINESSWIRE
27 Mar 2023

https://www.businesswire.com/news/home/20230316005317/en

BUSINESSWIRE
16 Mar 2023
Cancer biotech IMV hunts for a deal as its cash clock ticks down
Cancer biotech IMV hunts for a deal as its cash clock ticks down

16 Mar 2023

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/want-mvp-immuno-oncology-biotech-imv-searching-deal-its-cash-clock-ticks-down

Nick Paul Taylor FIERCE BIOTECH
16 Mar 2023

https://www.businesswire.com/news/home/20230309005329/en

BUSINESSWIRE
09 Mar 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty